Other Clinical Trial - Control Of Fluid Balance Guided by Body Composition

Clinical Trial Summary

Bioimpedance-guided fluid management in peritoneal dialysis patients may provide better protection of residual renal function over 1 year period, compared with management guided by clinical information alone - such as blood pressure, body weight, and physician's physical examination.

See also
Status	Clinical Trial	Phase
Completed	`NCT00563446` - Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia	N/A
Not yet recruiting	`NCT04427514` - Continuous Ambulatory Peritoneal Dialysis With Telemedicine	N/A
Terminated	`NCT01478698` - The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients	Phase 1

See also

Status

Clinical Trial

Phase

Completed

NCT00563446 - Study of the Efficacy of Darbepoetin Alfa in the Treatment of Renal Anemia

N/A

Not yet recruiting

NCT04427514 - Continuous Ambulatory Peritoneal Dialysis With Telemedicine

N/A

Terminated

NCT01478698 - The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients

Phase 1

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01887262
Study type	Interventional
Source	Seoul National University Hospital
Contact
Status	Completed
Phase	N/A
Start date	July 2013
Completion date	July 2016

Control Of Fluid Balance Guided by Body Composition Monitoring in Patients on PeritoneAl dialySiS — COMPASS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms